3-(2-(heteroaryl)-pyridin-4-yl)-5-(trifluoromethyl)-1, 2, 4-oxadiazole derivatives as HDAC6 inhibitors

The present invention relates to compounds as described herein, which are useful as histone deacetylase 6 (HDAC6) inhibitors. The invention also relates to pharmaceutical compositions comprising these compounds and their use in therapy. 本发明涉及如本文所述的化合物，其用作组蛋白脱乙酰基酶6(HDAC6)抑制剂。本发明还涉及包含这些化合物的药物组合物以及它们在疗...

Full description

Saved in:
Bibliographic Details
Main Authors SALAS SOLANA JORGE, CARCELLER GONZALEZ ELENA, ORTEGA MUNOZ ALBERTO
Format Patent
LanguageChinese
English
Published 18.03.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds as described herein, which are useful as histone deacetylase 6 (HDAC6) inhibitors. The invention also relates to pharmaceutical compositions comprising these compounds and their use in therapy. 本发明涉及如本文所述的化合物，其用作组蛋白脱乙酰基酶6(HDAC6)抑制剂。本发明还涉及包含这些化合物的药物组合物以及它们在疗法中的用途。
Bibliography:Application Number: CN202080055779